Factor IX (FIX) clinical trials

An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B

This study looks at how well a new gene therapy, HEMGENIX, works and if it's safe for people with haemophilia B in the long term. It also compares HEMGENIX to standard Factor IX treatment to understand its effects better.